Global G-Protein Coupled Receptors (GPCRs) Market Growth (Status and Outlook) 2023-2029

Global G-Protein Coupled Receptors (GPCRs) Market Growth (Status and Outlook) 2023-2029

G protein–coupled receptors ( GPCRs ) which are also known as seven-transmembrane domain receptors , 7TM receptors , heptahelical receptors , serpentine receptor , and G protein–linked receptors ( GPLR ), constitute a large protein family of receptors , that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses.

LPI (LP Information)' newest research report, the “G-Protein Coupled Receptors (GPCRs) Industry Forecast” looks at past sales and reviews total world G-Protein Coupled Receptors (GPCRs) sales in 2022, providing a comprehensive analysis by region and market sector of projected G-Protein Coupled Receptors (GPCRs) sales for 2023 through 2029. With G-Protein Coupled Receptors (GPCRs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world G-Protein Coupled Receptors (GPCRs) industry.

This Insight Report provides a comprehensive analysis of the global G-Protein Coupled Receptors (GPCRs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on G-Protein Coupled Receptors (GPCRs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global G-Protein Coupled Receptors (GPCRs) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for G-Protein Coupled Receptors (GPCRs) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global G-Protein Coupled Receptors (GPCRs).

The global G-Protein Coupled Receptors (GPCRs) market size is projected to grow from US$ 86 million in 2022 to US$ 103.3 million in 2029; it is expected to grow at a CAGR of 2.6% from 2023 to 2029.

Asia Pacific region is expected to grow at a significant rate during the forecast period owing to the economic development of the countries such as China and India owing to increasing government investment in the biotechnology and biopharmaceutical sector, increasing life expectancy, rising per capita income and unmet market needs in the region.

This report presents a comprehensive overview, market shares, and growth opportunities of G-Protein Coupled Receptors (GPCRs) market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Pharmaceutical
Biopharmaceutical

Segmentation by application
Immune System Disease
Oncology Disease
Other Disease

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific, Inc
EMD (Merck) Millipore
PerkinElmer, Inc
Cisbio Bioassays
Enzo Life Sciences, Inc.
DiscoveRx Corporation
Promega Corporation
Abcam plc
HD Biosciences Co. Ltd.

Please note: The report will take approximately 2 business days to prepare and deliver.